Boothbay Fund Management’s Milestone Pharmaceuticals MIST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-30,790
| Closed | -$72.7K | – | 1456 |
|
2024
Q4 | $72.7K | Buy |
30,790
+11
| +0% | +$26 | ﹤0.01% | 1161 |
|
2024
Q3 | $46.8K | Hold |
30,779
| – | – | ﹤0.01% | 1317 |
|
2024
Q2 | $40.6K | Hold |
30,779
| – | – | ﹤0.01% | 1256 |
|
2024
Q1 | $55.1K | Buy |
30,779
+3,191
| +12% | +$5.71K | ﹤0.01% | 1288 |
|
2023
Q4 | $46.1K | Hold |
27,588
| – | – | ﹤0.01% | 1365 |
|
2023
Q3 | $85.5K | Buy |
27,588
+2,412
| +10% | +$7.48K | ﹤0.01% | 1384 |
|
2023
Q2 | $71.8K | Hold |
25,176
| – | – | ﹤0.01% | 1427 |
|
2023
Q1 | $99.2K | Hold |
25,176
| – | – | ﹤0.01% | 1692 |
|
2022
Q4 | $99.7K | Sell |
25,176
-48,576
| -66% | -$192K | ﹤0.01% | 1546 |
|
2022
Q3 | $678K | Sell |
73,752
-58,749
| -44% | -$540K | 0.02% | 946 |
|
2022
Q2 | $815K | Sell |
132,501
-51,697
| -28% | -$318K | 0.02% | 813 |
|
2022
Q1 | $1.18M | Buy |
184,198
+9,735
| +6% | +$62.5K | 0.03% | 658 |
|
2021
Q4 | $1.14M | Hold |
174,463
| – | – | 0.03% | 585 |
|
2021
Q3 | $996K | Sell |
174,463
-50,295
| -22% | -$287K | 0.03% | 614 |
|
2021
Q2 | $1.24M | Buy |
224,758
+16,426
| +8% | +$90.3K | 0.04% | 517 |
|
2021
Q1 | $1.21M | Hold |
208,332
| – | – | 0.05% | 409 |
|
2020
Q4 | $1.4M | Buy |
208,332
+9,624
| +5% | +$64.5K | 0.05% | 308 |
|
2020
Q3 | $1.46M | Buy |
198,708
+150,908
| +316% | +$1.1M | 0.09% | 267 |
|
2020
Q2 | $181K | Buy |
+47,800
| New | +$181K | 0.01% | 684 |
|